Serum copper and zinc and the risk of death from cancer and cardiovascular disease
To investigate the association of serum copper and zinc with mortality from cancer and cardiovascular disease, the authors performed a case-control analysis of data obtained in a Dutch prospective follow-up study. Cancer (n = 64) and cardiovascular disease (n = 62) deaths and their matched controls were taken from a cohort of 10,532 persons examined in 1975-1978. Trace elements were measured in baseline serum samples, which had been stored during the six to nine years of follow-up. The adjusted risk of death from cancer and cardiovascular disease was about four times higher for subjects in the highest serum copper quintile (> 1.43 mg/liter) compared with those with normal levels. The excess mortality observed in subjects with low copper status suggests a U-shaped relation. No significant change in the risk of death from cancer and cardiovascular disease was found for subjects with low or high baseline levels of serum zinc. However, a protective effect of a high zinc status on the risk of cancer and cardiovascular disease is compatible with the data. For definitive conclusions, analysis of larger prospective data sets is recommended.
- Research Organization:
- Erasmus Univ. Medical School, Rotterdam (Netherlands)
- OSTI ID:
- 6600028
- Journal Information:
- Am. J. Epidemiol.; (United States), Vol. 128:2
- Country of Publication:
- United States
- Language:
- English
Similar Records
Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors
Related Subjects
COPPER
BIOLOGICAL EFFECTS
HEALTH HAZARDS
ZINC
BLOOD SERUM
CARCINOGENESIS
CARDIOVASCULAR DISEASES
DATA ANALYSIS
ELEMENTS
MORTALITY
NEOPLASMS
TRACE AMOUNTS
DISEASES
HAZARDS
METALS
PATHOGENESIS
TRANSITION ELEMENTS
560300* - Chemicals Metabolism & Toxicology